<span>Lab stewardship program reduces unnecessary costs and improves patient care</span>
March 27, 2023

Lab stewardship program reduces unnecessary costs and improves patient care

A large, Chicago-based FQHC network wanted to optimize efficiency of testing, improve patient care and provide better, more accurate testing for their highrisk population, while also eliminating unnecessary testing expenses. The network, however, faced a lack of population health analytics tools and limited funding to invest in developing their own.
<span>Raising the voices in colon cancer screening</span>
March 27, 2023

Raising the voices in colon cancer screening

With proper screening, early detection of colorectal cancer often leads to a cure. Since the 1980s, incidents of colorectal cancer have declined—in fact, from 2011 to 2019, incidents dropped by about 1% each year. These promising statistics demonstrate the power of preventive screening.
<span>At-home FIT tests: How they help you detect colon cancer without getting a colonoscopy first</span>
March 21, 2023

At-home FIT tests: How they help you detect colon cancer without getting a colonoscopy first

When it comes to colorectal cancer, there is one statistic—a promising one—that stands out: 90% of patients survive beyond 5 years when colon cancer is caught early. Early detection is the key to catching and treating colorectal cancer (CRC). The American Cancer Society recommends that everyone ages 45 to 75 get screened for CRC—further guidelines suggest that those age 75 and older should discuss with their primary care provider about whether or not they should be screened.
<span>Lab partnership reduces gaps in care and improves quality performance</span>
March 14, 2023

Lab partnership reduces gaps in care and improves quality performance

A little more than 20 years ago, care delivery in California started to change. Large-scale independent physician associations (IPAs)—such as the subject of this case study—began taking on full-risk commercial contracts. These contracts, similar to more recent Medicare and ACO programs, were meant to improve patient care and reduce overall costs in a densely populated state. Since 2005, one large, California-based IPA has partnered with Labcorp to conduct yearly fecal occult blood test (FOBT) gap closure programs with a proven return track record of 30-40%. The success of this program is a result of the IPA care coordination team leveraging Labcorp’s data to identify patients with screening gaps and coordinate distribution of FIT testing home kits for patient collection. This made it easier for patients to fulfill screening, particularly in underserved populations.